ArticleDrug design, development and therapy2025

Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy.

Ying Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.